Form 4: Allovir Inc. Executive Sells Shares to Cover Tax Obligations

A Form 4 filing reveals that Allovir Inc.'s President and CFO, Vikas Sinha, sold shares to cover tax obligations related to vesting restricted stock units.

Summary

• Vikas Sinha, President and Chief Financial Officer of Allovir Inc., sold 3,186 shares of common stock on November 19, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $0.5485, with individual transactions ranging from $0.545 to $0.572.
• Following the transaction, Mr. Sinha directly owns 1,140,894 shares of Allovir Inc. common stock.
• Mr. Sinha also has indirect beneficial ownership of 16,674,766 shares held by ElevateBio LLC, where he serves as a director and CFO.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock sales for tax purposes, and does not indicate any positive or negative sentiment.

Management Comments

• The sales were automatic and not in the discretion of the Reporting Person.
• The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Industry Context

Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. This filing is typical for executives who receive stock-based compensation.

Comparison to Industry Standards

• Form 4 filings are a common occurrence for publicly traded companies, particularly around vesting periods for stock-based compensation.
• The sale of shares to cover tax obligations is a standard practice among executives receiving equity compensation.
• The reported price range is within the expected volatility for a stock of this nature.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but is generally considered a routine transaction.

Key Dates

Keywords

Form 4, insider trading, stock sale, tax obligations, restricted stock units, beneficial ownership, Allovir Inc., Vikas Sinha, ElevateBio LLC